JP Morgan Chase
MGNX icon

JP Morgan Chase’s MacroGenics MGNX Stock Holding History

JP Morgan Chase’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-100
Closed -$3K – 6668
2021
Q2 		$3K Sell
100
-12,600
-99% -$369K ﹤0.01% 6180
2021
Q1 		$404K Buy
+12,700
New +$308K ﹤0.01% 4812

Other funds holding MGNX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

JP Morgan Chase's MGNX Position: Q1 2026 in Review

JP Morgan Chase increased its MacroGenics (MGNX) stake by 313% in Q1 2026, buying an estimated $38.4K and bringing the position to 23,775 shares worth $65.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6061.

JP Morgan Chase first reported a position in MGNX in Q4 2013 and has held it in 50 quarters since. The position peaked at $15.1M in Q1 2024. 109 funds tracked by Wall St. Rank hold MGNX as of Q1 2026.

  • JP Morgan Chase held 23,775 shares of MacroGenics worth $65.6K as of Q1 2026.
  • JP Morgan Chase bought 18,022 MacroGenics shares in Q1 2026, an estimated $38.4K.
  • MacroGenics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6061 holding.
  • JP Morgan Chase first reported a position in MacroGenics in Q4 2013 and has held it in 50 quarters since.
  • JP Morgan Chase's MacroGenics position peaked at $15.1M in Q1 2024.
  • 109 funds tracked by Wall St. Rank held MacroGenics as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.